U.S. Food and Drug Administration Reasoning in Approval Decisions When Efficacy Evidence Is Borderline, 2013-2018.
Perrine JaniaudTelba IronyEstelle Russek-CohenSteven N GoodmanPublished in: Annals of internal medicine (2021)
U.S. Food and Drug Administration.
Keyphrases